Isolated Protein S Deficiency Presenting as Thromboembolic Pulmonary Arterial Hypertension in a Young Child

Krishna Kumar Yadav^1, , S N Singh¹ and Anit Parihar^1,

¹Department of Pediatrics, King George's Medical University, Lucknow, India

Cite this paper:
Krishna Kumar Yadav, S N Singh and Anit Parihar. Isolated Protein S Deficiency Presenting as Thromboembolic Pulmonary Arterial Hypertension in a Young Child. American Journal of Medical Case Reports. 2014; 2(12):283-287. doi: 10.12691/ajmcr-2-12-7

Abstract

A 13 months male child presented with progressive dyspnea of three months and recent cyanosis. Cardio-respiratory examination revealed tachypnea, cyanosis, left parasternal heave and loud P2. Echocardiography revealed thrombus in pulmonary artery and severe pulmonary arterial hypertension. Tests for throbmophilia demonstrated protein S deficiency. Treatment included anticoagulants, sildenafil, bosentan and supportive measures without embolectomy. The child get stabilized soon with echocardiographic evidence of thrombus resolution, however, tachypnea and oxygen dependency persisted. He discharged on bosentan, warfarin and home O2 inhalation. Follow-up CT pulmonary angiography showed organized thrombus in pulmonary artery and cystic lesions in lungs. During 14 months of follow-up he remained tachypneic and oxygen dependent despite discharge medication and additional sildenafil, and subsequently died of right ventricular failure and pulmonary hemorrhage. Thromboembolic pulmonary arterial hypertension due to protein S deficiency can present in early childhood and treatment with anticoagulants, bosentan and sildenafil without embolectomy may not be appropriate.

Keywords:
protein S deficiency thromboembolism pulmonary arterial hypertension Wegener granulomatosis Langerhans cell histiocytosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Beghetti M. Pediatric pulmonary hypertension: monitoring progress and identifying unmet needs. Eur Respir Rev 2009; 111: 18-23.
[2]	Van Loon RL, Roofthooft MT, Hillege HL, ten Harkel AD, van Osch-Gevers M, Delhaas T et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 2011; 124: 1755-64.
[3]	Sompradeekul S, Minipan M. Clinical features and management of chronic thromboembolic pulmonary hypertension in Thai. J Med Assoc Thai 2010; 93 Suppl 1: S79-85.
[4]	Wagh S, Anadure R, Dutta V, Sandhu MS, Trehan R. Isolated protein S deficiency presenting as catastrophic systemic arterial and subsequently venous thrombosis. AMJ 2012; S, 8: 424-28.
[5]	Comp PC, Nixan RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clinical Invest 1984; 74: 2082-8.
[6]	Januario G, Ramroop S, Shingadia DV, Novelli V. Postinfectious purpura fulminans secondary to varicella-induced protein S deficiency. Pediatr Infect Dis J 2010; 29: 981-3.
[7]	Bergmann F, Hoyer PF, D’Angelo SV, Mazzola G, Oestereich C, Barthels M, D’Angelo A. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol 1995; 89: 610-14.
[8]	Colorio CC, Martinuzzo ME, Forastiero RR, Pombo G, Adamczuk Y, Carreras LO. Thombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2001; 12: 427-32.
[9]	Ardoin SP, Fels E. ANCA-Associated Vasculitis. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, editors. Nelson Texbook of Pediatrics. 19th ed. Philadelphia: Elsevier Sauders; 2012.p 874-876.
[10]	Wang Q, Xia W, Zhao DY. Isolated pulmonary Langerhans cell hitsiocytosis in a two year- old child: case report and literature review. Zhonghua Er Ke Za Zhi 2012; 50: 146- 50.
[11]	Odame I, Li P, Lau L, Doda W, Nosewarthy M, Babyn P, et al. Pulmonary Langerhanscell histiocytosis: A variable disease in childhood. Pediatr Blood Cancer 2006; 47: 889-93.
[12]	Donti A, Formigari R, Ragni L, Manes A, Galie N, Picchio FM. Pulmonary arterial hypertension in the pediatric age. J Cardiovasc Med (Hagerstown) 2007; 8: 72-7.
[13]	Lang IM, Chronic thromboembolic pulmonary hypertension – not so rare after all. N Eng J Med 2004; 350: 2236-38.
[14]	Sawyer T, Antle A, Studer M, Thompson M, Perry S, Mahnke CB. Neonatal pulmonary artery thrombosis presenting as persistent pulmonary hypertension of the newborn. Pediatr Cardiol 2009; 30: 520-22.
[15]	Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, etal. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Eng J Med 2004; 350: 2257-64.
[16]	Piovella F, D’Armini AM, Barone M, Tapson VF. Chronic thrmboembolic pulmonary hypertension. Semin Thromb Hemost 2006; 32: 848-55.
[17]	Sdogou T, Kossiva L, Kakleas K, Platokouki H, Tentolouri T, Georgouli H etal. Deep vein thrombosis and pulmonary embolism in a child with diabetic ketoacidosis and protein S deficiency: a case report. Horm Res Paediatr 2013; 79: 114-8.
[18]	Benyounes B, Crestani B, Couvelard A, Vissuzaine C, Aubier M. Steroid responsive pulmonary hypertension in a patient with Langerhans cell granulocytosis (Histocytosis X). Chest 1996; 110: 284-86.
[19]	Dahlback B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost 2007; 98: 90–6.
[20]	Hilgart ner MW, Corrigan JJ Jr. Coagulation disorders. In: Miller DR, Baehner RL, Blood Diseases of Infancy and Childhood. 7th edn. Philadelphia: Mosby; 1995. p. 971-75.
[21]	Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: an updated review. Curr Opin Cardiol 2008; 23: 555-9.
[22]	Hislop AA, Moledina S, Foster H, Schulze-Neick I, Haworth SG. Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children. Eur Resp J 2011; 38: 70-77.